Cargando…
Increased expression of PD-L1 by the human papillomavirus 16 E7 oncoprotein inhibits anticancer immunity
Cytotoxic T lymphocyte dysfunction is frequently associated with PD-L1/PD-1 pathway activation, and is a principal obstacle in cancer therapy. In the present study, the mechanisms underlying the human papillomavirus (HPV)-induced evasion of cervical cancer cells to the host immune system via the pro...
Autores principales: | Liu, Chaoqi, Lu, Jiao, Tian, Huiqun, Du, Wei, Zhao, Lin, Feng, Jing, Yuan, Ding, Li, Zhiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367331/ https://www.ncbi.nlm.nih.gov/pubmed/28075442 http://dx.doi.org/10.3892/mmr.2017.6102 |
Ejemplares similares
-
Localisation of Human Papillomavirus 16 E7 Oncoprotein Changes with Cell Confluence
por: Laurson, Joanna, et al.
Publicado: (2011) -
Immunohistochemical Detection of Human Papillomavirus 16 E7 Oncoprotein in Cervical Lesions
por: Zhu, Jiang, et al.
Publicado: (2021) -
Human papillomavirus 16 E7 oncoprotein alters the expression profiles of circular RNAs in Caski cells
por: Zheng, Si-Rong, et al.
Publicado: (2018) -
Human papillomavirus type 16 E7 oncoprotein mediates CCNA1 promoter methylation
por: Chalertpet, Kanwalat, et al.
Publicado: (2015) -
Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors
por: Paolini, Francesca, et al.
Publicado: (2021)